Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study
Crossref DOI link: https://doi.org/10.1186/s13063-017-1825-7
Published Online: 2017-02-21
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chappell, Francesca M.
del Carmen Valdés Hernández, Maria
Makin, Stephen D.
Shuler, Kirsten
Sakka, Eleni
Dennis, Martin S.
Armitage, Paul A.
Muñoz Maniega, Susana
Wardlaw, Joanna M.
Funding for this research was provided by:
Wellcome Trust (088134/Z/09/A)